VABYSMOⓇ (faricimab-svoa)

Welcome to the VABYSMO LinkedIn page: your go-to hub for learning about this innovative treatment. Follow this page to stay up to date on VABYSMO and visit www.vabysmo-hcp.com for more information. Intended for US healthcare professionals only. Please see the Important Safety Information in full VABYSMO Prescribing Information: bit.ly/VABPI Community Guidelines: Join the conversation. All comments, stories, pictures, and videos posted to the VABYSMO page will be moderated. We reserve the right to remove any comments or posts that do not meet our community guidelines. Comments or questions that are offensive, threatening, or otherwise inappropriate will not be posted to our LinkedIn page. Aside from VABYSMO, do not mention or discuss any other medicines by name—Genentech’s or anyone else’s. Please do not post any comments that reference additional pharmaceutical brands, including specific medicines, products, or services. Being aware of and reporting side effects is very important. If you know or experience any side effects, we encourage you to report it immediately to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription products directly to the FDA at 1-800-FDA-1088 or by visiting www.fda.gov/medwatch. The information provided on this page is for informational purposes only, and is not intended to replace the advice or clinical judgment of any qualified medical professional. Genentech does not control and is not responsible for the accuracy of any opinions, advice, information, or other comments posted on this page by third parties. © 2025 Genentech USA, Inc. M-US-00027555(v1.0) 04/25